Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Also note reflux, bloating, abdominal pain, early fullness, and any medications you use for nausea, constipation, or reflux
Liver Fat and NAFLD Models Participants with elevated liver fat showed reductions of over 80%, with high-dose recipients achieving normal liver fat levels
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
Tack, J., Caenepeel, P., Piessevaux, H., Cuomo, R
Der aktuelle Forschungsstand wird als prklinisch bis frh klinisch eingestuft
US$ 29.70
US$ 23.51
US$ 27.16
US$ 21.70
US$ 26.83
US$ 20.34
US$ 20.44
US$ 20.40
US$ 24.59
